Form 4: Blue Bird CFO Sells Shares Under 10b5-1 Plan
Insider Trading Report
Blue Bird Corporation's Chief Financial Officer, Razvan Radulescu, sold 7,984 shares of common stock for approximately $50.39 per share under a pre-arranged trading plan.
Summary
- Razvan Radulescu, Chief Financial Officer of Blue Bird Corp., sold 7,984 shares of common stock.
- The shares were sold at a weighted average price of $50.39 per share, with individual transaction prices ranging from $50.01 to $50.99.
- The transaction occurred on December 10, 2025.
- This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Radulescu on September 12, 2025.
- Following the transaction, Mr. Radulescu beneficially owns 49,087 shares of Blue Bird common stock.
Sentiment
Score: 5
Explanation: A neutral to slightly negative sentiment. While an insider sale reduces direct ownership, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling based on non-public information.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate insider information.
Negatives
- An insider sale, even under a 10b5-1 plan, reduces the CFO's direct equity stake in the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view the sale by a CFO as a slight negative, though the 10b5-1 plan context reduces its significance. It represents a reduction in direct insider alignment.
Key Dates
| Date | Description |
|---|---|
| 09/12/2025 | Date Rule 10b5-1 trading plan was adopted by Razvan Radulescu. |
| 12/10/2025 | Date of transaction where 7,984 shares were sold. |
Recommendation
holdThe filing reports a routine insider sale by the CFO under a pre-arranged 10b5-1 plan. This type of transaction is generally not considered a strong signal for future stock performance, as it's often for personal financial planning rather than a reflection of the company's immediate prospects. Therefore, it does not provide sufficient new information to change an existing investment thesis, warranting a 'hold' recommendation.
Keywords
Blue Bird Corp, BLBD, Form 4, Insider Sale, Razvan Radulescu, CFO, 10b5-1 plan, Equity Transaction, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.